Sandra Degroat
Psychiatric/Mental Health · Avondale, AZNPI 1144625799
Payments from drug & device makers
Across 173 payments — averaging $25.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Johnson & Johnson$849
- E.r. Squibb & Sons, L.L.C.$619
- AbbVie$445
- Teva Pharmaceuticals USA, Inc.$375
- Alkermes, Inc.$362
- plus $815 from 12 others
What the payments were for
- Food & beverage$4,41999%
- Education$501%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 35 | $1,004 |
| Johnson & Johnson | 13 | $849 |
| E.r. Squibb & Sons, L.L.C. | 9 | $619 |
| AbbVie | 54 | $445 |
| Teva Pharmaceuticals USA, Inc. | 15 | $375 |
| Alkermes, Inc. | 6 | $362 |
| Neurocrine Biosciences, Inc. | 6 | $185 |
| Otsuka America Pharmaceutical, Inc. | 10 | $138 |
| Supernus Pharmaceuticals, Inc. | 6 | $124 |
| Braeburn Inc. | 1 | $110 |
| Indivior Inc. | 4 | $59 |
| Noven Therapeutics, LLC | 4 | $57 |
| Vanda Pharmaceuticals Inc. | 3 | $41 |
| Corium, LLC | 2 | $29 |
| Eisai Inc. | 2 | $28 |
| Noven Pharmaceuticals, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$768
- LYBALVI$488
- ARISTADA$417
- COBENFY$265
- CAPLYTA$236
- INVEGA TRINZA$150
- INGREZZA$122
- AUSTEDO$122
- BRIXADI$110
- ARISTADA INITIO$104
How this compares
$4,470 in reported general payments places this provider in the 90th percentile of 1,230 psychiatric/mental health providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 47 | $163,385 |
| Abilify MaintenaAripiprazole | 43 | $125,041 |
| Fluphenazine Hcl | 13 | $4,727 |
| Aripiprazole | 52 | $4,225 |
| Divalproex Sodium ErDivalproex Sodium | 107 | $2,700 |
| Trazodone Hcl | 116 | $1,739 |
| Quetiapine Fumarate | 135 | $1,492 |
| Clozapine | 66 | $1,203 |
| Duloxetine Hcl | 28 | $1,043 |
| Divalproex Sodium | 99 | $838 |
| Haloperidol Decanoate | 17 | $832 |
| Prazosin Hcl | 53 | $777 |
| Fluoxetine Hcl | 83 | $701 |
| Mirtazapine | 85 | $698 |
| Haloperidol | 58 | $674 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $849 | $163,38547 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $138 | $125,04143 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,230 psychiatric/mental health providers in Arizona.
Other psychiatric/mental health in Avondale
- Elizabeth ElliottPhoenix$363K
- Diane StrickerGilbert$281K
- Russell HorningPhoenix$254K
- Stacy UnderwoodMesa$252K
- Angela ChenTempe$107K
- Brett LeifsonScottsdale$90K
- Claire ReecePhoenix$88K
- Bryan LazaroScottsdale$61K
- Luis FongPhoenix$59K
- Jeffrey EdelmanPeoria$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.